COMPARISON OF THE EFFECTIVENESS OF CARBETOCIN AND OXYTOCIN IN DECREASING POSTOPERATIVE BLOOD LOSS AMONG WOMEN UNDERGOING CAESAREAN SECTION IN WARRI, DELTA STATE, NIGERIA: A RANDOMIZED CONTROLLED TRIAL.
Not Applicable
Recruiting
- Conditions
- Circulatory SystemPregnancy and ChildbirthSurgery
- Registration Number
- PACTR202201739991276
- Lead Sponsor
- OKWUCHUKWU ONYEOWUZONI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Women providing consent
Term pregnancy
Live singleton pregnancy
Parity less than 5
Exclusion Criteria
History of atonic postpartum haemorrhage
Uterine fibroids
Multiple gestations
Placenta praevia
Grand multiparity
Use of anticoagulant
Use of tocolytics
History of coagulopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie carbetocin's uterotonic effects compared to oxytocin in postpartum hemorrhage prevention?
How does carbetocin compare to oxytocin in reducing postoperative blood loss in caesarean sections in low-resource settings?
Are there specific biomarkers that predict differential response to carbetocin versus oxytocin in caesarean section patients?
What are the known adverse event profiles of carbetocin compared to oxytocin in obstetric surgical procedures?
What combination therapies or alternative uterotonic agents show promise in reducing postpartum hemorrhage in caesarean sections?